Actively Recruiting

Age: 29Days - 18Years
All Genders
NCT06742060

The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU

Led by Children's Hospital of Fudan University · Updated on 2026-02-17

100

Participants Needed

1

Research Sites

109 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Central diabetes insipidus (CDI),a disease caused by the decrease of AVP (a hormone involved in the control of water-electrolyte balance ) secretion and characerized by polyuria, is a common complication after neurosurgerical intervention and there is a lack of diagnostic criteria.Since the surgry casuses damage to patients' AVP-secreting neuronal cells, transient CDI (t-CDI) usually occurs 24-48h postoperatively and gradually resolves in about 10 days.However,permanent CDI (p-CDI) occurs in a small percentage of patients.Copeptin is a fragment of AVP, which has been shown to response the secretion of AVP.Multiple international studies have identified clinical applications for the use of copeptin to differentially diagnose adults with CDI , to assess electrolyte disturbances associated with AVP regulation, and to predict postoperative CDI after pituitary surgery.This study aims to investigate the trend of serum copeptin levels and its clinical value for postoperative CDI in pediatric patients after neurosurgerical intervention in ICU.

CONDITIONS

Official Title

The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU

Who Can Participate

Age: 29Days - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female, age 69 days and <18 years
  • After neurosurgical intervention
  • Patient agrees to follow study requirements including follow-up visits
Not Eligible

You will not qualify if you...

  • Structural diseases of the genitourinary system that could cause nephrogenic diabetes insipidus
  • Symptoms of diabetes insipidus before surgery
  • Diabetes mellitus with HbA1c >8.5%
  • Use of drugs causing excessive drinking and urination, such as sodium-glucose cotransporter-2 inhibitors and diuretics
  • Lack of follow-up data after 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China, 201102

Actively Recruiting

Loading map...

Research Team

G

gangfeng Yan

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU | DecenTrialz